Exact Sciences, Mayo Clinic Launch Real-World Impact Study for Cologuard

Exact Sciences and the Mayo Clinic announced today that they have initiated a study to analyze the real-world impact of the company’s Cologuard colorectal cancer diagnostic test on colorectal cancer screening, incidence, and mortality rates.

The Voyage study is a prospective, observational study designed to enroll more than 150,000 people with a valid Cologuard order. The researchers will follow participants for at least seven years to evaluate clinical outcome.

Source: https://www.genomeweb.com/business-news/exact-sciences-mayo-clinic-launch-real-world-impact-study-cologuard